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Background: To assess procedural feasibility and early safety of hybrid coronary revascularization, combining off-pump left internal mammary 
artery grafting to the left descendent coronary artery (LAD) through an inferior J-hemisternotomy (JOPCAB) and percutaneous coronary intervention 
(PCI) of non-LAD lesions.
methods: A total of 100 consecutive patients with multivessel coronary artery disease involving LAD were included in this prospective registry.
results: JOPCAB was performed prior to PCI in 89 (89%) patients, and PCI was scheduled prior to surgery in 11 (11%) patients with total occlusion 
of a non-LAD artery. Two of these patients were treated by CABG, as revascularization by PCI failed. We chose to re-operate one patient with LIMA 
graft thrombosis by conventional CABG, as the LAD had shown diffuse arteriosclerotic disease at JOPCAB. Thus, the procedural success rate was 97%. 
One month after completed hybrid intervention, we observed no deaths. There was one stroke on the fourth postoperative day and two procedure-
related, but no spontaneous myocardial infarctions.
conclusions: Our prospective registry documented excellent procedural feasibility and one-month safety of coronary hybrid revascularization 
combining JOPCAB with PCI.
